TMDX
TransMedics Group, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$89.98
+3.45%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 668.5M | 605.5M | 441.5M | 241.6M | 93.5M |
| Cost of Revenue | 276.1M | 242.7M | 179.5M | 87.5M | 28.2M |
| Gross Profit | 392.3M | 362.8M | 262.1M | 154.1M | 65.3M |
| Operating Expenses | |||||
| R&D Expense | 92.5M | 69.1M | 56.0M | 63.3M | 26.8M |
| SG&A Expense | 212.2M | 185.2M | 168.6M | 119.6M | 69.9M |
| General & Admin Expense | 150.8M | 180.9M | 168.6M | 119.6M | 51.7M |
| Selling & Marketing Expense | 3.6M | 4.3M | — | — | 18.2M |
| Other Expenses | 6.1M | — | — | — | — |
| Total Operating Expenses | 310.7M | 254.2M | 224.6M | 182.8M | 96.7M |
| Cost and Expenses | 586.9M | 496.9M | 404.0M | 270.4M | 124.9M |
| Operating Income (EBIT) | 81.6M | 108.6M | 37.5M | (28.7M) | (31.4M) |
| Non-Operating | |||||
| Interest Income | 5.9M | — | — | 12.5M | 900.0K |
| Interest Expense | 21.2M | 13.8M | 14.4M | 10.8M | 3.7M |
| Net Interest Income | (15.4M) | (13.8M) | (14.4M) | 1.7M | (2.8M) |
| Other Non-Op Income/Expense | (9.1M) | (1.1M) | (1.7M) | 2.1M | (4.7M) |
| Non-Operating Income (excl Interest) | (12.2M) | (12.7M) | (12.7M) | (12.8M) | 1.0M |
| EBT (Pre-Tax Income) | 72.6M | 107.5M | 35.8M | (26.7M) | (36.2M) |
| Income Tax Expense | (79.1M) | (82.8M) | 316.0K | (1.6M) | 66.0K |
| Bottom Line | |||||
| Net Income | 151.7M | 190.3M | 35.5M | (25.0M) | (36.2M) |
| Earnings from Cont. Ops | 151.7M | 190.3M | 35.5M | (25.0M) | (36.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | 154.3M | 190.3M | 35.5M | (25.0M) | (36.2M) |
| Per Share | |||||
| Basic EPS | $4.42 | $5.60 | $1.07 | ($0.77) | ($1.23) |
| Diluted EPS | $3.86 | $4.87 | $1.01 | ($0.77) | ($1.23) |
| Revenue Per Share | $19.33 | $17.81 | $13.29 | $7.43 | $3.16 |
| Shares | |||||
| Basic Shares Outstanding | 34.6M | 34.0M | 33.2M | 32.5M | 29.6M |
| Diluted Shares Outstanding | 40.7M | 40.5M | 35.2M | 32.5M | 29.6M |
| Profitability Metrics | |||||
| EBITDA | 120.0M | 148.5M | 69.9M | (7.7M) | (29.0M) |
| D&A | 26.2M | 27.2M | 19.8M | 8.2M | 3.5M |
| EBIT | 93.8M | 121.3M | 50.2M | (15.9M) | (32.4M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026